Search results for "body ma"

showing 10 items of 1464 documents

Subcutaneous and omental fat expression of adiponectin and leptin in women with polycystic ovary syndrome

2007

Objective To assess message expression of adiponectin and leptin in visceral and SC fat in women with polycystic ovary syndrome (PCOS) and in control women. Design Prospective clinical trial. Setting Academic medical centers in Mexico City, Mexico and New York, New York. Patient(s) Women with PCOS and control women. Intervention(s) Surgical biopsies of visceral (omental) and subcutaneous (SC) adipose tissue, fasting blood samples, and ultrasound measurements of visceral and SC fat. Main Outcome Measure(s) Messenger RNA assessment of adiponectin and leptin in adipose tissue samples; serum measurements of adiponectin, leptin, glucose, insulin, and hormone levels; measurements of fat quantity …

AdultBlood GlucoseLeptinmedicine.medical_specialtymedicine.medical_treatmentAbdominal FatNew YorkSubcutaneous FatAdipokineAdipose tissueBody Mass IndexSettore MED/13 - EndocrinologiaInsulin resistanceInternal medicineAbdominal fat adiponectin leptin polycystic ovary syndrome insulin resistancemedicineHumansInsulinProspective StudiesRNA MessengerMexicoUltrasonographyAdiponectinbusiness.industryLeptinInsulinnutritional and metabolic diseasesObstetrics and Gynecologymedicine.diseasePolycystic ovaryEndocrinologyReproductive MedicineCase-Control StudiesFemaleAdiponectinInsulin ResistancebusinessBody mass indexhormones hormone substitutes and hormone antagonistsPolycystic Ovary Syndrome
researchProduct

Erratum: Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of do…

2016

Although higher dietary intakes of magnesium (Mg) seem to correspond to lower diabetes incidence, research concerning Mg supplementation in people with or at risk of diabetes is limited. Thus, we aimed to investigate the effect of oral Mg supplementation on glucose and insulin-sensitivity parameters in participants with diabetes or at high risk of diabetes compared with placebo. A literature search in PubMed, EMBASE, SCOPUS, Cochrane Central Register of Controlled Trials and Clinicaltrials.gov without language restriction, was undertaken. Eligible studies were randomized controlled trials (RCTs) investigating the effect of oral Mg supplementation vs placebo in patients with diabetes or at h…

AdultBlood GlucoseMale0301 basic medicinemedicine.medical_specialtyCalorieMagnesium supplementationMedicine (miscellaneous)030209 endocrinology & metabolismCarbohydrate metabolismlaw.inventionDouble blind03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicineDiabetes mellitusDiabetes MellitusmedicineHumansMagnesiumAgedRandomized Controlled Trials as TopicGlucose tolerance test030109 nutrition & dieteticsNutrition and Dieteticsmedicine.diagnostic_testbusiness.industryMedicine (all)Medicine (miscellaneous); Medicine (all); Nutrition and DieteticsFastingGlucose Tolerance TestMiddle Agedmedicine.diseaseObesityEndocrinologyMeta-analysisDietary Supplementsmagnesium Nutrition diabetes Dietetics glucose metabolismFemalebusinessBody mass indexEuropean Journal of Clinical Nutrition
researchProduct

Salivary composition in obese vs normal-weight subjects: towards a role in postprandial lipid metabolism?

2015

In the pathophysiological context of obesity, oral exposure to dietary fat can modulate lipid digestion and absorption but underlying in-mouth mechanisms have not been clearly identified. Therefore we tested the hypothesis that salivary components related to dietary fat sensitivity would differ according to BMI and postprandial lipid metabolism in young men. Saliva was collected from 9 normal-weight (BMI=22.3±0.5 kg/m2) and 9 non-morbid obese (BMI=31.7±0.3 kg/m2) men before a 8 h-postprandial metabolic exploration test involving the consumption of a 40 g fat-meal, in which obese subjects revealed a delayed postprandial lipid metabolism. Nine salivary characteristics (flow, protein content, …

AdultBlood GlucoseMaleSalivamedicine.medical_specialtyproteolysis030309 nutrition & dieteticsEndocrinology Diabetes and Metabolism[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionMedicine (miscellaneous)Context (language use)salivary compositionBody Mass Index03 medical and health sciencesThinnessInternal medicinelipid metabolismmedicineLipolysisHumansObesitySalivaMeals030304 developmental biology0303 health sciencesNutrition and Dieteticsobesebusiness.industryLipid metabolism[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismPostprandial PeriodDietary Fats3. Good healthPostprandialEndocrinologylipolysismedicine.symptombusinessEnergy MetabolismWeight gainBody mass indexLipid digestion[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Ensayo no aleatorizado de un programa de fisioterapia continuo frente a interválico para pacientes con sobrepeso y síndrome coronario agudo

2020

Resumen: Presentamos un ensayo no aleatorizado de un programa de fisioterapia continuo frente a interválico para pacientes con sobrepeso y síndrome coronario agudo. Objetivo: Detectar diferencias entre un programa de fisioterapia (PF) continuo (CONT) y uno interválico (INT) en pacientes con sobrepeso y síndrome coronario agudo, respecto a parámetros antropométricos, analíticos, frecuencia cardiaca de reposo, adherencia a la intervención, desgaste, seguridad y tolerancia. Diseño: Estudio multicéntrico cuasiexperimental con diseño pre-post, no aleatorizado con muestreo por conveniencia con 2 brazos de tratamiento. Emplazamiento: Centros de prevención cardiaca comunitaria (Departamentos de Sal…

AdultBlood GlucoseMaleTime FactorsNon-Randomized Controlled Trials as TopicWarm-Up Exercise030204 cardiovascular system & hematologyBody Mass Index03 medical and health sciences0302 clinical medicineHeart RateHumansSíndrome coronario agudo030212 general & internal medicinePhysiotherapyFisioterapiaTriglyceridesAgedlcsh:R5-920PreventionGeneral MedicineMiddle AgedOverweightOriginalesLipidsExercise TherapyPrevenciónCool-Down ExerciseSobrepesoPhysical EnduranceFemaleAcute coronary syndromeWaist Circumferencelcsh:Medicine (General)Family PracticeAtención Primaria
researchProduct

Pasta consumption and connected dietary habits: Associations with glucose control, adiposity measures, and cardiovascular risk factors in people with…

2019

Background: Pasta is a refined carbohydrate with a low glycemic index. Whether pasta shares the metabolic advantages of other low glycemic index foods has not really been investigated. The aim of this study is to document, in people with type-2 diabetes, the consumption of pasta, the connected dietary habits, and the association with glucose control, measures of adiposity, and major cardiovascular risk factors. Methods: We studied 2562 participants. The dietary habits were assessed with the European Prospective Investigation into Cancer and Nutrition (EPIC) questionnaire. Sex-specific quartiles of pasta consumption were created in order to explore the study aims. Results: A higher pasta con…

AdultBlood GlucoseMalecardiovascular risk factorsAdolescentSaturated fatlcsh:TX341-641Type 2 diabetesAdded sugarDietary habitCardiovascular risk factorArticleSettore MED/13 - EndocrinologiaYoung AdultEnvironmental healthDiabetes mellitusGlucose controlmedicinebody mass index; cardiovascular risk factors; dietary habits; glucose control; pasta consumption; type 2 diabetesDietary CarbohydratesHumansHypoglycemic AgentsChilddietary habitsBody mass indexAdiposityAgedNutrition and Dieteticsbusiness.industryPasta consumptionConfoundingfood and beveragesType 2 diabetesFeeding BehaviorMiddle Agedmedicine.diseaseObesityEuropean Prospective Investigation into Cancer and NutritionDiabetes Mellitus Type 2ItalyCardiovascular DiseasesChild PreschoolFemalebusinessBody mass indexlcsh:Nutrition. Foods and food supplyFood Science
researchProduct

Effects of hypocaloric diets with different glycemic indexes on endothelial function and glycemic variability in overweight and in obese adult patien…

2013

Background & aims: The role of glycemic index of the diet in glucose control and cardiovascular prevention is still not clear. The aim of this study was to determine the effects of hypocaloric diets with different glycemic indexes and glycemic loads on endothelial function and glycemic variability in nondiabetic participants at increased cardiovascular risk. Methods: Forty nondiabetic obese participants were randomly assigned to a three-month treatment with either a low glycemic index (LGI; n ¼ 19) or high glycemic index (HGI; n ¼ 21) hypocaloric diet with similar macronutrient and fiber content. Endothelial function was measured as flow-mediated dilatation (FMD) of the brachial artery befo…

AdultBlood GlucoseMalemedicine.medical_specialtyAdolescentBrachial ArteryOverweightCritical Care and Intensive Care MedicineGastroenterologyBody Mass IndexYoung AdultInsulin resistanceRisk FactorsWeight lossInternal medicineWeight LossGlycemic loadDiabetes MellitusmedicineBody Fat DistributionHumansInsulinendothelial function glycemic variability diet glycemic index glycemic load cardiovascular riskEndotheliumObesitySettore MED/49 - Scienze Tecniche Dietetiche ApplicateCaloric RestrictionGlycemicNutrition and Dieteticsbusiness.industryMiddle AgedOverweightmedicine.diseaseGlycemic indexEndocrinologyCardiovascular DiseasesGlycemic IndexBody CompositionFemaleInsulin Resistancemedicine.symptomEnergy IntakebusinessBody mass indexDietingClinical Nutrition
researchProduct

Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin lev…

2013

OBJECTIVE: Currently available studies that fully analyse the metabolic parameters in patients with prolactinoma are scarce and discordant. The aim of this study was to evaluate the metabolic effects of cabergoline (CAB) treatment in patients with newly diagnosed prolactinoma in relation to disease control and CAB dosage. DESIGN: This is a retrospective clinical-based therapy analysis. PATIENTS: Forty-three patients with prolactinoma (eight men, 35 women), aged 33·65 ± 11·23 years, were evaluated metabolically at baseline and after 12 months of CAB treatment. MEASUREMENTS: Body mass index (BMI), systolic and diastolic blood pressure, waist circumference (WC), lipid profile, haemoglobinA1c (…

AdultBlood GlucoseMalemedicine.medical_specialtyCabergolineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPituitary neoplasmSettore MED/13 - EndocrinologiaBody Mass IndexYoung AdultEndocrinologyInsulin resistanceInternal medicineCabergolineMedicineHumansPituitary NeoplasmsProlactinomaErgolinesProlactinomaAdiposityRetrospective Studiesmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryInsulinmedicine.diseaseLipidsProlactinBlood pressureEndocrinologyDopamine AgonistsMetabolomeFemaleInsulin ResistanceWaist CircumferencebusinessLipid profileBody mass indexmedicine.drugClinical endocrinology
researchProduct

Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population.

2004

We investigated the association of C1431T and Pro12Ala polymorphisms at the peroxisome proliferator-activated receptor γ (PPARγ) locus with plasma lipids and insulin resistance-related variables, according to diabetes status, in a large and representative Asian population from Singapore consisting of 2,730 Chinese, 740 Malays, and 568 Indians. Moreover, we estimated the diabetes risk and examined gene-nutrient interactions between these variants and the ratio of polyunsaturated fatty acid to saturated fat (SFA) in determining body mass index (BMI) and fasting insulin. We found differential effects of these gene variants. The Pro12Ala polymorphism was more associated with plasma lipids and f…

AdultBlood GlucoseMalemedicine.medical_specialtyDiabetes riskAsiaSaturated fatmedicine.medical_treatmentMutation MissensePeroxisome proliferator-activated receptorLocus (genetics)QD415-436BiologyBiochemistryPolymorphism Single NucleotidepolymorphismBody Mass IndexEndocrinologyRisk FactorsfatDiabetes mellitusInternal medicinemedicineDiabetes MellitusHumansInsulinAllelechemistry.chemical_classificationperoxisome proliferator-activated receptorInsulinFatty AcidsCell BiologyMiddle Agedmedicine.diseaseLipidsPPAR gammaEndocrinologychemistryFatty Acids UnsaturatedFemaleInsulin ResistancedietBody mass indexJournal of lipid research
researchProduct

How often patients on insulin therapy measure postprandial glycemia and modify insulin doses accordingly? From an on-line survey in insulin-treated d…

2019

Abstract Introduction Controlling postprandial glycemia (PPG) is important to achieve optimal glycemic control, but few studies have evaluated how often is measured and evaluated. Objectives To evaluate how often patients on insulin therapy measure PPG and modify insulin doses accordantly. As secondary objectives, we evaluated the factors conditioning elevated PPG and associated issues. Material and methods Cross-sectional observational study based on a web-based survey from an unselected sample of adult insulin-treated patients. A p-value of  Results 1251 patients (68% women, 38.9 ± 13 years [mean ± SD], body mass index (BMI) 24.2 ± 4.2 kg/m2, diabetes duration 17.4 ± 12.8 years, insulin d…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatment030209 endocrinology & metabolismDisease03 medical and health sciences0302 clinical medicineEndocrinologySurveys and QuestionnairesDiabetes mellitusInternal medicineInternal MedicineHumansHypoglycemic AgentsInsulinMedicine030212 general & internal medicineGlycemicGlycated HemoglobinBlood glucose monitoringmedicine.diagnostic_testbusiness.industryBlood Glucose Self-MonitoringInsulinGeneral MedicineMiddle AgedPostprandial Periodmedicine.diseaseCross-Sectional StudiesDiabetes Mellitus Type 1PostprandialDiabetes Mellitus Type 2SpainHyperglycemiaFemaleObservational studysense organsbusinessBody mass indexDiabetes Research and Clinical Practice
researchProduct

A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients.

1998

The presence of insulin resistance in 20 male nondiabetic patients with familial combined hyperlipidemia (FCH) and 20 controls of similar age and body mass index (BMI) was investigated using the minimal model method modified by the administration of insulin and an oral glucose tolerance test. The peripheral sensitivity of insulin, expressed as the insulin sensitivity index (Si), was 1.91 ± 1.05 and 2.86 ± 1.19 × 10−4 · min−1 · mU/L in FCH patients and controls, respectively (P < .01), and the corresponding value for the peripheral utilization of glucose independently of insulin (Sg) was 1.70 ± 1.13 in FCH patients and 2.35 ± 0.60 × 10−2 · min−1 in controls (P < .02). In the FCH group, the S…

AdultBlood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentHyperlipidemia Familial CombinedFatty Acids NonesterifiedBody Mass IndexEndocrinologyWaist–hip ratioInsulin resistanceStatistical significanceInternal medicinemedicineDiabetes MellitusHumansInsulinObesityPancreatic hormoneTriglyceridesApolipoproteins Bbusiness.industryInsulinCholesterol HDLArea under the curveAge FactorsMiddle Agedmedicine.diseaseObesityEndocrinologyGlucoseCase-Control StudiesBody ConstitutionInsulin ResistancebusinessBody mass indexMetabolism: clinical and experimental
researchProduct